Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter phase 4 study of gestrinone dosing schedules and abnormal uterine bleeding in endometriosis or adenomyosis
ChiCTR-TRC-12002327Phase 4Completed
- Sponsor
- Beijing Obstetrics and Gynecology Hospital
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Gestrinone in endometriosis and adenomyosis, sponsored by Beijing Obstetrics and Gynecology Hospital. Primary endpoint: Vaginal bleeding pattern and duration. Started Apr 2012; status: completed.
02
Drugs
Gestrinone
03
Conditions
endometriosisadenomyosis
Beyond the preview
Go deeper on ChiCTR-TRC-12002327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002327.